What? Companies still have R&D rebate whether the expenditure is here and disagree, CVI will convert the $26M warrant at 5c after further positive clinical trial updates from VAXINIA, OASIS and Azer-Cel in 6 months time (why wouldn't they when the pps is at 15c????) so IMU will have $50M at the start of 2026 after they receive the 2024 R&D rebate of around $20M. This is with IMU spending around $15M per quarter similar to last quarter and without any further cost cutting which they've mentioned.
IMU Price at posting:
3.4¢ Sentiment: None Disclosure: Held
A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.
(20min delay)